A major discovery in cancer study is emerging with the use of nanobodies to reactivate dysfunctional p53. This crucial tumor suppressor protein is frequently disabled in several forms of tumors, resulting uncontrolled https://bookmarkjourney.com/story21949660/mini-antibodies-revive-p53-new-potential-hope-for-malignant-treatment